Cardiac retransplantation is an efficacious therapy for primary cardiac allograft failure.
Publication/Presentation Date
5-7-2008
Abstract
BACKGROUND: Although orthotopic heart transplantation has been an effective treatment for end-stage heart failure, the incidence of allograft failure has increased, necessitating treatment options. Cardiac retransplantation remains the only viable long-term solution for end-stage cardiac allograft failure. Given the limited number of available donor hearts, the long term results of this treatment option need to be evaluated.
METHODS: 709 heart transplants were performed over a 20 year period at our institution. Repeat cardiac transplantation was performed in 15 patients (2.1%). A retrospective analysis was performed to determine the efficacy of cardiac retransplantation. Variables investigated included: 1 yr and 5 yr survival, length of hospitalization, post-operative complications, allograft failure, recipient and donor demographics, renal function, allograft ischemic time, UNOS listing status, blood group, allograft rejection, and hemodynamic function.
RESULTS: Etiology of primary graft failure included transplant arteriopathy (n = 10), acute rejection (n = 3), hyperacute rejection (n = 1), and a post-transplant diagnosis of metastatic melanoma in the donor (n = 1). Mean age at retransplantation was 45.5 +/- 9.7 years. 1 and 5 year survival for retransplantation were 86.6% and 71.4% respectively, as compared to 90.9% and 79.1% for primary transplantation. Mean ejection fraction was 67.3 +/- 12.2% at a mean follow-up of 32.6 +/- 18.5 mos post-retransplant; follow-up biopsy demonstrated either ISHLT grade 1A or 0 rejection (77.5 +/- 95.7 mos post-transplant).
CONCLUSION: Cardiac retransplantation is an efficacious treatment strategy for cardiac allograft failure.
Volume
3
First Page
26
Last Page
26
ISSN
1749-8090
Published In/Presented At
Atluri, P., Hiesinger, W., Gorman, R. C., Pochettino, A., Jessup, M., Acker, M. A., Morris, R. J., & Woo, Y. J. (2008). Cardiac retransplantation is an efficacious therapy for primary cardiac allograft failure. Journal of cardiothoracic surgery, 3, 26. https://doi.org/10.1186/1749-8090-3-26
Disciplines
Medicine and Health Sciences
PubMedID
18462494
Department(s)
Department of Surgery
Document Type
Article